𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PSS20 COST-UTILITY ANALYSIS OF A PRN (AS NEEDED) TREATMENT SCHEDULE WITH RANIBIZUMAB (LUCENTIS®) IN WET AMD BASED ON CLINICAL EVIDENCE

✍ Scribed by K Moeremans; L Gerlier; P Mitchell; M Gallagher; G Vincze


Book ID
118614842
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
69 KB
Volume
13
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.